Single-Chain Polymer Nanoparticles for Application in Nanomedicine - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 39

3. Long, T.C., et al., Titanium dioxide (P25) produces reactive oxygen species
in immortalized brain microglia (BV2): implications for nanoparticle
neurotoxicity. Environmental Science & Technology, 2006. 40 (14): p.
4346-4352.
4. Dobrovolskaia, M.A., and McNeil, S.E., Immunological properties
of engineered nanomaterials. Nature Nanotechnology, 2007. 2 :
p. 469-478.
5. Shimada, A., Kawamura, N., Okajima, M., Kaewamatawong, T., Inoue,
H., and Morita,T., Translocation pathway of the intratracheally instilled
ultrafine particles from the lung into the blood circulation in the mouse.
Toxicologic Pathology, 2006. 34 : p. 949-957.
6. Lockman, P.R., et al., Nanoparticle surface charges alter blood - brain
barrier integrity and permeability. Journal of Drug Targeting, 2004.
12 (9-10): p. 635-641.
7. Gupta, U., and Jain, N.K., Non-polymeric nano-carriers in HIV/AIDS drug
delivery and targeting. Advanced Drug Delivery Reviews. 62 (4-5): p.
478-490.
8. E. Soussan, S.C., Blanzat, M., and Rico-Lattes, I., Drug delivery by soft
matter: matrix and vesicular carriers. Angewandte Chemie International
Edition English, 2009. 48 : p. 274-288.
9. Doshi, N., and Mitragotri, S., Designer biomaterials for nanomedicine.
Advanced Functional Materials, 2009. 19 : p. 3843-3854.
10. Sharma, P., and Garg, S., Pure drug and polymer based nanotechnologies
for the improved solubility, stability, bioavailability and targeting of anti-
HIV drugs. Advanced Drug Delivery Reviews. 62 (4-5): p. 491-502.
11. Wong, H.L., et al., Nanotechnology applications for improved delivery
of antiretroviral drugs to the brain. Advanced Drug Delivery Reviews.
62 (4-5): p. 503-517.
12. Bharali, D.J., et al., Nanoparticles and cancer therapy: a concise review
with emphasis on dendrimers. International Journal of Nanomedicine,
2009. 4 : p. 1-7.
13. Gaucher, G., Marchessault, R.H., and Leroux, J.C., Polyester-based
micelles and nanoparticles for the parenteral delivery of taxanes. Journal
of Controlled Release. 143 (1): p. 2-12.
14. Keller, M., Nanomedicinal delivery approaches for therapeutic siRNA.
International Journal of Pharmaceutics, 2009. 379 (2): p. 210-211.
15. Santos-Magalhães, N.S., and Mosqueira, V.C.F., Nanotechnology applied
to the treatment of malaria. Advanced Drug Delivery Reviews. 62 (4-5):
p. 560-575.
16. Romero, E.L., and Morilla, M.J., Nanotechnological approaches against
Chagas disease. Advanced Drug Delivery Reviews. 62 (4-5): p. 576-588.